@article{ATM30601,
author = {Timo Zippelius and Georg Matziolis and Eric Röhner and Christoph Windisch and Chris Lindemann and Patrick Strube},
title = {Psychological distress and health-related quality of life in patients with bone marrow edema syndrome},
journal = {Annals of Translational Medicine},
volume = {7},
number = {20},
year = {2019},
keywords = {},
abstract = {Background: The aim of the study was to investigate psychological distress and health-related quality of life (HrQoL) in patients with bone marrow edema syndrome (BMES) of the hip or knee joint.
Methods: This retrospective study included patients with the diagnosis BMES treated in the period 2016–2017. As well as analyzing the epidemiological data (age, sex, vascular disease, hypertension, etc.), we used the Hospital Anxiety and Depression Scale (HADS) to document anxiety and depression and the five-level version of the EuroQol Group’s EQ-5D instrument (EQ-5D-5L) to assess HrQoL and compared it to historical controls of the healthy population.
Results: The study group comprised 56 patients (26 females, 30 males) with a mean age of 55.8 (range, 15–84) years. HADS: there was no difference between the study and control cohorts in the rates of anxiety (P=0.595) or depression (P=0.241). EQ-5D-5L: the HrQoL was significantly lower in the patients with BMES than in the healthy controls both for parameters of the EQ-5D-5L index and in the various age groups. No difference in HrQoL was seen between BMES of the hip and the knee or among the different radiological stages of BMES.
Conclusions: The patients with BMES displayed a clear reduction in HrQoL, but this was not associated with psychological distress with regard to significant anxiety and depression. Patients with BMES and a high score for anxiety and depression are at great risk of chronic pain, and we recommend they should receive psychological counseling.},
issn = {2305-5847}, url = {https://atm.amegroups.org/article/view/30601}
}